Levonorgestrel intrauterine device can be left in place for five years

BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7151.149a (Published 11 July 1998) Cite this as: BMJ 1998;317:149
  1. M Harrison-Woolrych, Senior medical assessor,
  2. J M Raine, Group manager
  1. Medicines Control Agency, London SW8 5NQ

    EDITOR—Mansour and Guillebaud have drawn attention to the effective duration of use of the levonorgestrel intrauterine device.1 The Medicines Control Agency has reviewed clinical data on the product authorised in the United Kingdom (Mirena). After advice …

    View Full Text

    Sign in

    Log in through your institution